1. Sean Renahan CIMA, ACMA, BA (Hons) 2:1
Twickenham, Middlesex TW2 | M: 07733 004429 | E: sean.renahan@gmail.com
LinkedIn: www.linkedin.com/in/seanrenahan
PROFESSIONAL PROFILE
A versatile commercially aware Finance Director with high integrity and a consistent track record of success gained in complex
PLC's and SME's across Pharmaceutical, Manufacturing, FMCG and Healthcare sectors, covering EMEA, Japan & US.
A trusted senior executive with experience of managing and developing high performing teams across multi -sites and countries,
and taking ownership for delivery of corporate projects, trouble shooting and restoring confidence in business units.
Specialising in strategic direction, FP&A, organisation, systems and process improvement and driven by customer satisfaction.
NOTABLE CAREER HIGHLIGHTS
 Trusted to set up a new Business Unitand delivered increased revenue of £25m through geographic expansion,improved
margins,new product releases and productrationalisation and was thekey point of contact with EMEA HQ.
 Successfully divested £300mproductportfolio and transition to acquiringcompany
 Achieved 75% improvement in compliance by automating invoicingprocess.
 Improved margins by 30% through successful transition fromagent to distributor model.
 Developed Budget/Forecasts in Hyperion Planning,providinggreater visibility by movingaway from spreadsheet models.
 Reduced DSO from 270 to 150 days resultingin reduction of €2m working capital requirement.
 Secured £30m fundingto launch new business unit.
 Kicked off Financeefficiency review, leadingto development of FinanceVision,and FinanceTransformation program.
 Launched management reporting, KPI’s and dashboards to review key business driversand driveperformance.
 Improved forecastingaccuracy for EMEA from +/-15% to +/- 3% leadingto greater confidence about direction of business.
 Recognised as a talented future leader and selected to attend INSEAD Leadership Journey program at Fontainebleau
CAREER SUMMARY
NOV 2020 – PRESENT PHARMACOSMOS UK: FINANCE DIRECTOR UK & IE
Subsidiary of Danish Pharma Company – Turnover £20m with 60 employees
 Provided strategic leadership,resultingin revenue growth of >30%, and improved profitmargins by 25%
 Responsiblefor Finance,Supply Chain,Business Intelligence& CRM System
 Implementation of paperless invoiceprocessing
 Developed Business Dashboards usingPower BI aligned with strategic direction of the organisation
JAN 2020 – NOV 2020 OLIVANDA LTD: FREELANCE FINANCE DIRECTOR/CONSULTANT
 Provided adviceto business on expansion to new markets, scenario analysisoptions,market shareassumptions
 Developed an activity plan for Business Readinessteamprior to S4 HANA implementation
JAN 2019 – DEC 2019 SUNOVION PHARMA EUROPE: DIRECTOR, FINANCE & BUSINESS SERVICES
Subsidiary of Top 10 Japanese Pharma Company – Turnover £5m with 50 employees
 Provided effective leadership and development of Company strategy, includingorganic/inorganicgrowth activities,
challengingassumptions and decision makingand providingfinancial analysisand guidance on Company activities,plans,
targets and business drivers.
 Identified and initiated action to achievea 15% reduction in OperatingExpenses recovering from a loss-making entity to
breakingeven in 2020.
 Reviewed and streamlined several business policies and processes savingsignificantman hours and improved quality of
information availableto the organisation.
 Led Finance,IT, Supply Chain & Contracting/Procurement teams
 Delivered monthly/quarterly/annual management and statutory reporting
 Risk management of foreign currency exposure
 Responsiblefor financial,tax,auditingand legal requirements. Primary pointof contact with external auditor & HMRC.

2. NOV 2004 – NOV 2018 ASTELLAS PHARMA EMEA
Top 15 Global Pharma Company – Turnover €2.5Bn with 4000 employees
NOV 2015 – NOV 2018 FINANCE DIRECTOR, PROJECT LEAD – SPECIAL PROJECTS
 FinanceTransformation – Design lead
o SME on FinanceTransformation preparingfor transition to Shared Service Centre BPO, requiringbest-in-class L3/L4
process mapping
o Designed a standard reportingsuite reducingtotal landscapefrom400 to 40 reports
 Presented Change ImpactAssessment to business units in preparation for ERP transition fromSAP ECC to SAP S4/HANA.
 Managed the divestment of a €300m business unitthrough providingeffective leadership,communication and strategy
adviceacross EMEA and Japan
o Introduced revenue recognition model takinginto accountthe phased transition to the purchasingcompany
o Developed a strongbusiness partnership with the acquiringcompany resultingin a successful transition.
OCT 2014 – OCT 2015 FINANCE DIRECTOR (VARIOUS)
Entrusted to several trouble-shooting roles:
Hungary
o Led a Financeand Logistics team of 5 staff (Turnover €20m, OP €5m FTE 40) followingan abrupt change in
management.
o Successfully restored confidencein the operation and sourced a permanent Financial Director.
Czech & Slovak
o Appointed on an interim basis to introduceinternal control processes to the Czech office(Turnover €50m, OP €20m
FTE 90) resultingin the achievement of a clean J-Sox/Internal audit.
IT EMEA
o Appointed to backfill and lead a team of 5 IT experts with an expense budget of €80m as Interim Director of the
Planning& Controls division.
o Tasked with managing demand and capacity planning.
o Vendor engagement (Accenture & IBM).
o Management of software licences acrossEMEA.
JAN 2011 – SEP 2014 FINANCE DIRECTOR – SE EUROPE BUSINESS UNIT, SLOVENIA
 Appointed/relocated to Slovenia to startup and lead the South-East Europe Business Unitthrough the creation of 4 legal
entities.
 Grew the business to €37m turnover, €12m OP and over 100 employees.
 Recruited, trained and developed a high performing multi-siteteam of 10 Financeand Supply Chain.
 Delivered 100% compliance for Financial Reporting, month-end closeand internal controls.
 Responsiblefor Revenue, Expense, BalanceSheet & Cash flowBudget and Forecastingfor 4 entities covering 10 countries.
 Coordinated statutory and management reporting, medium-term planning,scenario planningand supply of life-saving
products as a key member of the management team providing BusinessPartnering supportto Medical and Marketing
functions.
 Established financial systems and processes for 4 legal entities across 9 countries and introduced management reports
encompassinginternal / external data, KPI’s and traffic lightingto improve market shareand OperatingProfit.
NOV 2008 – JAN 2011 DIRECTOR OF FINANCIAL PLANNING & ANALYSIS
 Responsiblefor establishingand communicating EMEA requirements for Budget/Forecasts to Business Units (TO €2.5bn).
 Management and co-ordination of the EMEA Financial Planningand Analysisteam with a focus on ensuringbusiness
objectives and budgets were met.
 Prepared financial and qualitativemanagement reports to supportstrategic planningobjectives coveringmultipletime
horizons (Quarterly,Annual & 5-year forecasts).
 Designed framework for Budgeting/Performance systems to allowrelevantFinancial and Management Reporting.
JUL 2006 – NOV 2008 MANAGER / EUROPEAN CONTROLLER
 Oversawcontrollingactivities across7 businessunits (25%of EMEA revenue).
 Owned design structure of management reporting system (Hyperion Planning).
 Analysed and evaluated performance againstbudget targets.
 Communicated and designed control framework for global Transfer Pricingmodel.
 Delivered strategic financial and commercial recommendations to non-Financeteams.

3. EARLY CAREER SUMMARY
JUL 2005 – JUL 2006 MANAGER / EUROPEAN CONTROLLER: ASTELLAS PHARMA EMEA
NOV 2004 – JUN 2005 INTERIM MANAGEMENT ACCOUNTANT: ASTELLAS PHARMA EMEA
AUG 2003 – JUL 2004 FINANCE MANAGER: AUTOMATIC MINIBAR SYSTEMS
JV between Minibar AG and Dometic – Turnover £8m/annum with 30 employees
NOV 2002 – JUL 2003 INTERIM MANAGER: COMPUTER 2000
Computer Distributor: US-owned Subsidiary – Turnover £800m/annum with 500 employees
AUG 2002 – OCT 2002 MANAGEMENT ACCOUNTANT: EDWARD JAMES INTERNATIONAL
Financial Services Outsourcing Company – Turnover £4m/annum with 45 employees
APR 2000 – JUL 2002 FINANCE & COMMERCIAL MANAGER: LEGAL & TRADE RISK MANAGEMENT SERVICES
Financial Services: US-owned Subsidiary – Turnover £8m/annum with 150 employees
SEP 1999 – APR 2000 FINANCIAL CONTROLLER – CONTRACT: HTC HEALTHCARE GROUP PLC